Psychiatry Research

Major Depression Clinical Trials


A double-blind, placebo-controlled study of an investigational medical food among SSRI-resistant outpatients with major depressive disorder (PI: E. Nelson)

Eligibility
• Adults (18-65 years old) with a diagnosis of current major depressive episode and currently treated with an SSRI antidepressant at adequate doses during the current episode for at least 8 weeks
• Outpatient

Patient Benefits
• Eligible participants may receive study medication and study-related procedures/visits at no cost, and compensation for time and travel

Contact Information
• Tracy Adleta
(513) 558-3249
Tracey.Adleta@uc.edu


A 12-week, double-blind, placebo-controlled trial of an investigational medication versus placebo in the treatment of binge eating disorder and comorbid depressive disorder (PI: E. Nelson)

Eligibility
• Adults (18-65 years old) with a diagnosis of binge eating disorder and a depressive disorder (major depression, dysthymia, minor depression, or brief recurrent depression)
• Outpatient

Patient Benefits
Eligible participants may receive study medication and study-related procedures/visits at no cost, and compensation for time and travel

Contact Information
Tracy Adleta
(513) 558-3249
Tracey.Adleta@uc.edu


Hypothalamic-pituitary-adrenal axis dysregulation and phenomenology of major depression: the HPA study (PI: E. Nelson)

Eligibility
• Adults (18-65 years old) with a diagnosis of current major depressive episode or adults (18-65 years old) who wish to participate as a healthy volunteer
• 2-day Inpatient stay on a research unit

Patient Benefits
Eligible participants may receive complete diagnostic interview and study-related procedures at no cost, and compensation for overnight stays, time, and travel

Contact Information
Tracy Adleta
(513) 558-3249
Tracey.Adleta@uc.edu


A pilot fMRI study of emotional processing in phenomenological subtypes of major depression (PI: E. Nelson)

Eligibility
• Adults (18-65 years old) with a diagnosis of current major depressive episode or adults (18-65 years old) who wish to participate as a healthy volunteer
• Outpatient
• MRI brain scan required

Patient Benefits
Eligible participants may receive complete diagnostic interview at no cost, and compensation for time and travel

Contact Information
Tracy Adleta
(513) 558-3249
Tracey.Adleta@uc.edu

Evaluation of omega-3 fatty acids as a treatment-adjunct in adolescent patients with major depressive disorder exhibiting partial response to SSRI medications:An open-label neuroimaging trial (PI: R. McNamara)

Eligibility
• Adolescents (12-18 years old) with a diagnosis of current major depressive episode and currently treated with an SSRI antidepressant at adequate doses
• Outpatient
• MRI brain scan required

Patient Benefits
Eligible participants may receive complete diagnostic interview, study medication, and study-related procedures/visits at no cost, and compensation for time and travel

Contact Information
Dr. Robert McNamara
(513) 558-5601
Robert.McNamara@uc.edu

Patients in waiting room.
More Information

Clinical Research Management

Amelia Nasrallah, Director
University of Cincinnati Academic Health Center
Department of Psychiatry and Behavioral Neuroscience
PO Box 670559
Cincinnati, Ohio 45267-0559

Phone: (513) 558-2226
Fax: (513) 558-4616
Email: amelia.nasrallah@uc.edu